development of gene therapy
gene-silencing
innovative strategies of gene
novel gene-therapy
leading cause of SCD
team
model LQT8
major cause of SCD
development of molecular therapies
prevention of SCD
leading cause of death
existing CPVT model
severe inherited arrhythmogenic diseases
broad range of molecular strategies
molecular bases of heritable arrhythmias
inherited arrhythmias Sudden cardiac death
relevant model
heart
development of regional inhomogeneity
comparative efficacy
comprehensive project
comprehensive approach
efficacy of different constructs
clinical translation of results
dominant catecholaminergic polymorphic ventricular tachycardia
coronary artery disease
rhythm disturbances
western countries
older subjects
protein expression
Long QT syndrome type
delivery
high risk effort
knock
valuable core of knowledge
electrical milieu
research
younger individuals
proposal
proarrhythmic events
promoters
pig
unexplored field
availability
years